Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AFIB OTCMKTS:EVARF OTCMKTS:MAGAA OTCMKTS:NMRD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.00$0.00▼$0.01$3K5.686,602 shs20 shsEVARFLombard Medical$0.00$0.00▼$0.00N/AN/AN/AN/AMAGAAMagna-Lab$0.01-22.0%$0.01$0.11▼$2.00$8K7.513,117 shs228 shsNMRDNemaura Medical$0.00$0.00$0.00▼$0.05N/A0.353,353 shs1,820 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical0.00%0.00%0.00%-50.00%-95.00%EVARFLombard Medical0.00%0.00%0.00%0.00%0.00%MAGAAMagna-Lab-22.23%+1.43%-15.48%-52.98%-90.41%NMRDNemaura Medical0.00%0.00%-50.00%-50.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.00$0.00▼$0.01$3K5.686,602 shs20 shsEVARFLombard Medical$0.00$0.00▼$0.00N/AN/AN/AN/AMAGAAMagna-Lab$0.01-22.0%$0.01$0.11▼$2.00$8K7.513,117 shs228 shsNMRDNemaura Medical$0.00$0.00$0.00▼$0.05N/A0.353,353 shs1,820 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical0.00%0.00%0.00%-50.00%-95.00%EVARFLombard Medical0.00%0.00%0.00%0.00%0.00%MAGAAMagna-Lab-22.23%+1.43%-15.48%-52.98%-90.41%NMRDNemaura Medical0.00%0.00%-50.00%-50.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus Medical 0.00N/AN/AN/AEVARFLombard Medical 0.00N/AN/AN/AMAGAAMagna-Lab 0.00N/AN/AN/ANMRDNemaura Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.00N/AN/A($0.03) per share0.00EVARFLombard MedicalN/AN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/A($1.52) per shareN/ANMRDNemaura MedicalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66M-$0.11N/AN/AN/A-272.74%-311.64%-11.57%8/7/2026 (Estimated)EVARFLombard MedicalN/AN/AN/AN/AN/AN/AN/AN/AN/AMAGAAMagna-Lab-$130K$0.180.04N/AN/AN/A-12.32%42,399.99%N/ANMRDNemaura MedicalN/A-$0.50N/AN/AN/AN/AN/AN/A8/10/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/AEVARFLombard MedicalN/AN/AN/AN/AN/AMAGAAMagna-LabN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus MedicalN/A1.851.57EVARFLombard MedicalN/AN/AN/AMAGAAMagna-LabN/AN/AN/ANMRDNemaura MedicalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%EVARFLombard MedicalN/AMAGAAMagna-LabN/ANMRDNemaura Medical4.41%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical5.21%EVARFLombard MedicalN/AMAGAAMagna-Lab15.30%NMRDNemaura Medical40.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical34029.91 million28.23 millionOptionableEVARFLombard Medical111N/AN/ANot OptionableMAGAAMagna-Lab201.18 millionN/ANot OptionableNMRDNemaura Medical4040.35 million24.04 millionNo DataEVARF, MAGAA, NMRD, and AFIB HeadlinesRecent News About These CompaniesNMRD Nemaura Medical Inc.June 18, 2025 | seekingalpha.comNemaura Medical (OTC:NMRD) Stock Quotes, Forecast and News SummaryAugust 25, 2024 | benzinga.comNemaura Medical Inc (NMRD)May 26, 2024 | investing.comNXNN Nexeon Medsystems IncMay 24, 2024 | seekingalpha.comNemaura Medical Stock (OTC:NMRD) Earnings Dates and Earning CallsFebruary 23, 2024 | benzinga.comMaxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETJanuary 22, 2024 | finance.yahoo.comNemaura Medical, Inc: Important Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finanznachrichten.deImportant Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finance.yahoo.comBuy Rating Affirmed for Nemaura Medical on sugarBEAT Prospects and Market ExpansionDecember 20, 2023 | markets.businessinsider.comNemaura Medical: Regulation Fd Disclosure, Financial Statements And ExhibitsDecember 15, 2023 | cbonds.comCNemaura Medical, Inc: Nemaura Medical Inc. Receives Positive Nasdaq Listing DecisionDecember 13, 2023 | finanznachrichten.deNemaura Medical Inc. Receives Positive Nasdaq Listing DecisionDecember 13, 2023 | finance.yahoo.comNemaura Medical (NMRD) Price Target Increased by 54.55% to 8.67November 27, 2023 | msn.comNemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic GrowthNovember 21, 2023 | finance.yahoo.comNemaura (NMRD) to Expand in UK With Metabolic Health ProgramNovember 17, 2023 | msn.comNemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)November 16, 2023 | finance.yahoo.comNemaura Medical, Inc: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business UpdateNovember 15, 2023 | finanznachrichten.deAcutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2MNovember 14, 2023 | seekingalpha.comNemaura Medical, Inc: Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsNovember 14, 2023 | finanznachrichten.deNemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsNovember 14, 2023 | finance.yahoo.comEVARF, MAGAA, NMRD, and AFIB Company DescriptionsAcutus Medical NASDAQ:AFIBAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Lombard Medical OTCMKTS:EVARFLombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.Magna-Lab OTCMKTS:MAGAA$0.0071 0.00 (-21.98%) As of 06/29/2026Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of disposable medical devices to enhance the effectiveness of magnetic resonance imaging in detection and diagnosis of heart disease. The company was founded in 1991 and is based in Plainview, New York. Magna-Lab Inc. is a subsidiary of Magna Acquisition LLC.Nemaura Medical OTCMKTS:NMRD$0.0001 0.00 (0.00%) As of 06/29/2026 02:27 PM EasternNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Charts That Could Change the Course of Summer Trading Short Squeeze Alert—Moderna Stock Surges on New Strategy These 3 Dividend Stocks Could Boost Your Income This July The Quantum Bubble Is Real Enough to Take Seriously Amazon Could Be About to Reap the Rewards of a Software Spending Boom Could Apple's China Play Be the Answer to Its Memory Pressure Problem? Even CEOs Need Cash: Insider Selling Is Not the Only Signal in AI Stocks Why Wall Street Still Sees Massive Upside for AeroVironment Stock Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
